Drug Alert: Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection – NOT FOR neonates and infants below one year old

Drug Alert: Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection – NOT FOR neonates and infants below one year old

by Kazeem Olalekan MRPharmS The Medicines and Healthcare products Regulatory Agency has just issued a Class 4 Drug Safety Alert for Wockhardt UK Ltd – Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection. Alert details Drug alert number EL (14)A/09 in connection with the

Read more

Cummulative Update

Cummulative Update

by Kazeem Olalekan Over the last month, a number of important alerts have been posted on the MHRA website which we, at bookapharmacist.com, will like to draw attention (NOTE: We continue to Tweet MHRA alerts on our Twitter page – @bookapharmacist under the hashtag #mhra – so be

Read more

Urgent: (Action Required within 5 days) – MHRA Class 3 Alert: Cyclizine Lactate Injection 50mg/ 1ml ampoules

Urgent: (Action Required within 5 days) – MHRA Class 3 Alert: Cyclizine Lactate Injection 50mg/ 1ml ampoules

by Kazeem Olalekan MRPharmS Cyclizine Lactate Injection 50mg/ 1ml ampoules PL 00156/0096 Martindale Pharmaceuticals Ltd is recalling all remaining unexpired ampoules of the above discontinued product as a precautionary measure. This is due to a GMP concern at a third-party supplier and their own site. It is likely

Read more

Take note: PPIs and emerging issues

Take note: PPIs and emerging issues

by Kazeem Olalekan MRPharmS In August 2009 we reported a potential interaction between Proton pump inhibitors (PPI) and Clopidogrel. Subsequent to that report, Lancet concluded that PPI does not interfere with the clinical benefits of clopidogrel. The case frustrated me because in one week I was asking

Read more

Class 3 Drug Alert: Novgos 3.6 mg Implant

Class 3 Drug Alert: Novgos 3.6 mg Implant

Action within 5 days Genus Pharmaceuticals Ltd is temporarily ceasing manufacture of the above product and recalling all remaining stock from pharmacy and wholesaler level. This is due to a small number of problems during implantation and the product is being withdrawn until the implantation system can

Read more

Class 2: Drug Alert – Gaviscon Advance

Class 2: Drug Alert – Gaviscon Advance

Gaviscon Advance Peppermint Flavour Oral suspension containing sodium alginate 500mg and potassium bicarbonate 100mg in 5ml PL 0063/0103 Batch Number Expiry Date Pack Size First Distributed 924471 1/08/2011 500 ml bottle 19/09/2009 925071 1/09/2011 500 ml bottle 19/09/2009 Reckitt Benckiser Healthcare (UK) Ltd are recalling the above

Read more